- Our Work
- Get Involved
Re: A Shorter Regimen for Rifampin-Resistant Tuberculosis
New England Journal of Medicine
In accordance with the increasing recognition of multidrug-resistant and extensively drug-resistant tuberculosis worldwide, we believe that routine prescription of this shorter regimen based on rifampin resistance alone will lead to undertreatment of many patients worldwide.
Tornheim J, Udwadia Z, Gupta A. Re: A Shorter Regimen for Rifampin-Resistant Tuberculosis. N Engl J Med. 2019 Spt 12; 381(11): e22. doi: 10.1056/NEJMc1905782.